The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.62
Bid: 41.66
Ask: 41.72
Change: 0.00 (0.00%)
Spread: 0.06 (0.144%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.62
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of £300m senior unsecured bond

12 Jul 2018 16:59

RNS Number : 5115U
Assura PLC
12 July 2018
 

12 July 2018

 

 

Assura plc

 

Successful pricing of £300 million senior unsecured bond

 

Assura plc ("Assura") is pleased to announce the pricing of its first sterling-denominated senior unsecured bond (the "Bond") in an aggregate principal amount of £300 million with a tenor of 10 years following a series of UK fixed income investor meetings which generated strong institutional demand. The Bond will bear interest at a rate of 3 per cent per annum. The Bond will be issued by Assura Financing plc and guaranteed by Assura and a number of the Assura group's subsidiaries.

Fitch Ratings Limited recently assigned Assura an investment grade rating of A- (stable outlook) and is expected to assign the Bond an investment grade rating of A-.

Following the issuance of the Bond, Assura's weighted average debt maturity will increase from 6.0 years to 8.3 years and the pro forma weighted average cost of debt will be 3.27%.

The Bond issuance is part of Assura's overall financing initiatives to further diversify its sources of funding and extend its debt maturity profile. The proceeds of the Bond issuance will be used for general corporate and working capital purposes.

Barclays Bank plc and HSBC Bank plc acted as joint active bookrunners. Banco Santander, S.A. acted as passive bookrunners. Assura was advised on the bond and credit rating by Rothschild & Co.

Jayne Cottam, Chief Financial Officer, commented:

"We are delighted to have achieved an A- rating from Fitch, which shows the strength of our business model. This, and the level of bond investor support we received, has enabled us to price, successfully, our debut unsecured public bond. The bond extends our maturity profile and provides access to a new capital market which provides further funding to allow us to execute on our £225 million pipeline."

- Ends -

 

 

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Jayne Cottam

Orla Ball

 

Edelman

 

Tel: 0203 047 2546

John Kiely

Brett Jacobs

Rob Yates

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2018, Assura's property portfolio was valued at £1,733 million.

Further information is available at www.assuraplc.com 

*EPRA is a registered trademark of the European Public Real Estate Association 

Assura plc LEI code: 21380026T19N2Y52XF72

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGGUAAMUPRGAP
Date   Source Headline
1st May 20242:30 pmRNSHolding(s) in Company
1st May 20247:00 amRNSNotice of Year End Results
30th Apr 20247:00 amRNSTotal Voting Rights
16th Apr 20247:40 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSScrip Dividend Declaration
22nd Mar 20242:18 pmRNSHolding(s) in Company
14th Mar 20248:30 amRNSScrip Calculation Price
6th Mar 20241:26 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSNotice of Dividend
8th Feb 20242:00 pmRNSCapital Markets Event
7th Feb 20242:33 pmRNSDirector/PDMR Shareholding
1st Feb 20249:32 amRNSTotal Voting Rights
16th Jan 20248:26 amRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSTrading Update
9th Jan 20248:59 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSScrip Dividend Declaration
21st Dec 20234:20 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSScrip Calculation Price
6th Dec 20232:57 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSNotice of Dividend
16th Nov 20237:00 amRNSAssura Plc Interim Results
8th Nov 20232:32 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSAppointment of Board Fellow
31st Oct 20237:00 amRNSNotice of Interim Results
31st Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20232:04 pmRNSDirector/PDMR Shareholding
9th Oct 202311:13 amRNSDirector/PDMR Shareholding
9th Oct 20238:11 amRNSScrip Dividend Declaration
9th Oct 20237:00 amRNSRefinancing of RCF & new sustainability linkage
9th Oct 20237:00 amRNSTrading Update
18th Sep 20239:51 amRNSVesting and sale of restricted shares
14th Sep 20239:20 amRNSScrip Calculation Price
31st Aug 20237:00 amRNSNotice of Dividend
24th Aug 20238:36 amRNSHolding(s) in Company
8th Aug 20235:05 pmRNSDirector/PDMR Shareholding
31st Jul 20239:57 amRNSTotal Voting Rights
24th Jul 20237:00 amRNSDevelopment update
14th Jul 20231:47 pmRNSDirector/PDMR Shareholding
13th Jul 20234:47 pmRNSExercise of Nil Cost Options under PSP
12th Jul 20234:36 pmRNSDirector/PDMR Shareholding
10th Jul 202312:38 pmRNSHolding(s) in Company
10th Jul 20239:20 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSScrip Dividend Declaration & Additional Listing
6th Jul 20232:47 pmRNSResult of AGM
6th Jul 202312:28 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSTrading Update
3rd Jul 20237:00 amRNSChange of Registered Office
29th Jun 20234:46 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSCompletion of 100th development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.